We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Neuromodulation Technology Effective for Diabetic Neuropathy Treatment

By HospiMedica International staff writers
Posted on 23 May 2018
Print article
Image: The novel stimulation device is designed to aid neuropathic nerve recovery (Photo courtesy of Xavant Technology).
Image: The novel stimulation device is designed to aid neuropathic nerve recovery (Photo courtesy of Xavant Technology).
A novel device treats peripheral diabetic neuropathy (PDN) by subjecting damaged nerves to pulsed radiofrequency (PRF) electromagnetic waves.

The therapeutic effect of the Xavant Technology (Pretoria, South Africa) Stimpod NMS460 is based on cellular metabolic activity induced by the electromagnetic energy beamed to a neuropathic nerve, which seems to change its characteristics, and in many cases causing the nerve to recover its normal function. There are typically four phases associated with such a PRF procedure: a stunning phase that provides immediate relief; a phase of post-procedural discomfort; a phase of beneficial clinical effect; and lastly, a possible phase that involves pain recurrence or paralysis.

To locate the affected sensory nerve, a monophasic square wave is delivered transcutaneously by a pen-shaped mapping probe. Once near the adjacent motor nerve, the stimulation causes fasciculation of the relevant muscle; the closer the probe, the stronger the fasciculation. When pure sensory nerves need to be located, patient feedback is used. The closer the mapping pen gets to the sensory nerve, the stronger the sensation will be. The Stimpod NMS460 then delivers the PRF waveform, which creates discomfort in a healthy sensory nerve; however, the sensation to a neuropathic nerve is usually very comfortable.

Recovery of sensory nerves can be measured by the comfort experienced at different levels of stimulus intensity. For example, treating a neuropathic nerve at 30 mA at the first treatment may be comforting. But as the nerve recovers, current intensity would need to be reduced in order to maintain a comfort level for the patient in subsequent treatments; this provides a quantifiable measure of progress. The same goes for motor nerves, but rather than the sensation, a progress judgment can be made on the intensity level of the fasciculation.

“We are thrilled to see that our technology continues to prove that it can impact positively on the population of diabetic patients to whom there are otherwise limited options of treatment, often plagued with exorbitant cost and severe side effects,” said Corlius Birkill, CEO of Xavant Technology, speaking at the 11th Diabetologists Conference, held during May 2018 in New York (NY, USA). “We attend conferences like these to spread awareness of a disruptive treatment option that truly embodies the vision of Xavant Technology, which is, to contribute to a healthy, vibrant and compassionate world.”

Diabetic neuropathies are thought to result from a diabetic microvascular injury involving small blood vessels that supply the nerves, in addition to macrovascular conditions that can accumulate in diabetic neuropathy. Conditions associated with diabetic neuropathy include third, fourth, or sixth cranial nerve palsy; mononeuropathy; mononeuropathy multiplex; diabetic amyotrophy; a painful polyneuropathy; autonomic neuropathy; and thoracoabdominal neuropathy.

Related Links:
Xavant Technology

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bilirubin Lamp
Bilibluelight

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.